Literature DB >> 17536017

Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury.

Patricia Redecha1, Rachel Tilley, Michael Tencati, Jane E Salmon, Daniel Kirchhofer, Nigel Mackman, Guillermina Girardi.   

Abstract

Fetal loss in patients with antiphospholipid (aPL) antibodies has been ascribed to thrombosis of placental vessels. However, we have shown that inflammation, specifically activation of complement with generation of the anaphylotoxin C5a, is an essential trigger of fetal injury. In this study, we analyzed the role of the procoagulant molecule tissue factor (TF) in a mouse model of aPL antibody-induced pregnancy loss. We found that either blockade of TF with a monoclonal antibody in wild-type mice or a genetic reduction of TF prevented aPL antibody-induced inflammation and pregnancy loss. In response to aPL antibody-generated C5a, neutrophils express TF potentiating inflammation in the deciduas and leading to miscarriages. Importantly, we showed that TF in myeloid cells but not fetal-derived cells (trophoblasts) was associated with fetal injury, suggesting that the site for pathologic TF expression is neutrophils. We found that TF expression in neutrophils contributes to respiratory burst and subsequent trophoblast injury and pregnancy loss induced by aPL antibodies. The identification of TF as an important mediator of C5a-induced oxidative burst in neutrophils in aPL-induced fetal injury provides a new target for therapy to prevent pregnancy loss in the antiphospholipid syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17536017      PMCID: PMC1988945          DOI: 10.1182/blood-2007-01-070631

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Effect of antisense oligonucleotides for tissue factor on hepatic ischemia-reperfusion injury in the rat.

Authors:  K Nakamura; M Okamoto; K Akioka; M Matsuyama; R Yoshimura; H Ushigome; Y Kadotani; Y Ohmori; N Yoshimura
Journal:  Transplant Proc       Date:  2001 Nov-Dec       Impact factor: 1.066

2.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

Authors:  B E Clausen; C Burkhardt; W Reith; R Renkawitz; I Förster
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

3.  Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.

Authors:  E Camerer; W Huang; S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Aberrations of the tissue factor pathway in patients positive for lupus anticoagulant.

Authors:  Y Wakita; H Wada; T Nakase; T Nakasaki; M Shimura; K Hiyoyama; Y Mori; E C Gabazza; M Nishikawa; K Deguchi; H Shiku
Journal:  Clin Appl Thromb Hemost       Date:  1999-01       Impact factor: 2.389

Review 5.  Tissue factor pathway and the antiphospholipid syndrome.

Authors:  R A Roubey
Journal:  J Autoimmun       Date:  2000-09       Impact factor: 7.094

6.  The thrombomodulin-protein C system is essential for the maintenance of pregnancy.

Authors:  Berend Isermann; Rashmi Sood; Rafal Pawlinski; Mark Zogg; Shawn Kalloway; Jay L Degen; Nigel Mackman; Hartmut Weiler
Journal:  Nat Med       Date:  2003-02-10       Impact factor: 53.440

7.  Tissue factor antisense oligonucleotides prevent renal ischemia-reperfusion injury.

Authors:  Masahide Matsuyama; Rikio Yoshimura; Kiyokazu Akioka; Masahiko Okamoto; Hidetaka Ushigome; Yayoi Kadotani; Tatsuya Nakatani; Norio Yoshimura
Journal:  Transplantation       Date:  2003-09-15       Impact factor: 4.939

Review 8.  Specificity of coagulation factor signaling.

Authors:  W Ruf; A Dorfleutner; M Riewald
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

9.  Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.

Authors:  V Michael Holers; Guillermina Girardi; Lian Mo; Joel M Guthridge; Hector Molina; Silvia S Pierangeli; Ricardo Espinola; Liu E Xiaowei; Dailing Mao; Christopher G Vialpando; Jane E Salmon
Journal:  J Exp Med       Date:  2002-01-21       Impact factor: 14.307

10.  Tissue factor as a proinflammatory agent.

Authors:  Maria I Bokarewa; James H Morrissey; Andrej Tarkowski
Journal:  Arthritis Res       Date:  2002-01-10
View more
  96 in total

1.  Tissue factor contributes to neutrophil CD11b expression in alpha-naphthylisothiocyanate-treated mice.

Authors:  James P Luyendyk; Kevin C Flanagan; C David Williams; Hartmut Jaeschke; Joyce G Slusser; Nigel Mackman; Glenn H Cantor
Journal:  Toxicol Appl Pharmacol       Date:  2010-11-09       Impact factor: 4.219

Review 2.  Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

Review 3.  Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome.

Authors:  Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 4.  Pathogenic role of antiphospholipid antibodies.

Authors:  J E Salmon; P G de Groot
Journal:  Lupus       Date:  2008-05       Impact factor: 2.911

5.  Tracing the molecular pathogenesis of antiphospholipid syndrome.

Authors:  Hartmut Weiler
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

6.  Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury.

Authors:  Patricia Redecha; Nico van Rooijen; Donald Torry; Guillermina Girardi
Journal:  Blood       Date:  2009-02-20       Impact factor: 22.113

Review 7.  The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome.

Authors:  Rohan Willis; E B Gonzalez; A R Brasier
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

8.  Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Sam S Edwin; Yeon Mee Kim; Joon Seok Hong; Luis F Goncalves; Lami Yeo; Moshe Mazor; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07

Review 9.  Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome.

Authors:  Paul R J Ames; Annamaria Margarita; Jose Delgado Alves
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

Review 10.  Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule.

Authors:  G Girardi; N Mackman
Journal:  Lupus       Date:  2008-10       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.